Concord Wealth Partners’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-62
Closed -$663 312
2025
Q4
$663 Hold
62
﹤0.01% 738
2025
Q3
$773 Hold
62
﹤0.01% 751
2025
Q2
$633 Hold
62
﹤0.01% 777
2025
Q1
$490 Hold
62
﹤0.01% 761
2024
Q4
$487 Hold
62
﹤0.01% 860
2024
Q3
$195 Hold
62
﹤0.01% 928
2024
Q2
$175 Hold
62
﹤0.01% 797
2024
Q1
$977 Hold
62
﹤0.01% 794
2023
Q4
$1.22K Hold
62
﹤0.01% 749
2023
Q3
$1.26K Hold
62
﹤0.01% 924
2023
Q2
$1.81K Hold
62
﹤0.01% 882
2023
Q1
$1.74K Hold
62
﹤0.01% 835
2022
Q4
$1.15K Buy
+62
New +$1.06K ﹤0.01% 1035
2022
Q3
Sell
-62
Closed -$2K 348
2022
Q2
$2K Hold
62
﹤0.01% 1002
2022
Q1
$2K Hold
62
﹤0.01% 1078
2021
Q4
$5K Buy
+62
New +$5.47K ﹤0.01% 933

Other funds holding CRNC

Concord Wealth Partners's CRNC Position: Q1 2026 in Review

Concord Wealth Partners sold out of Cerence (CRNC) in Q1 2026, closing a stake of 62 shares — an estimated $663 sold.

Concord Wealth Partners first reported a position in CRNC in Q4 2021 and held it in 16 quarters. The position peaked at $5K in Q4 2021. 195 funds tracked by Wall St. Rank hold CRNC as of Q1 2026.

  • Concord Wealth Partners reported no remaining Cerence position as of Q1 2026 after selling out during the quarter.
  • Concord Wealth Partners sold 62 Cerence shares in Q1 2026, an estimated $663.
  • Concord Wealth Partners first reported a position in Cerence in Q4 2021 and held it in 16 quarters.
  • Concord Wealth Partners's Cerence position peaked at $5K in Q4 2021.
  • 195 funds tracked by Wall St. Rank held Cerence as of Q1 2026.

Based on Concord Wealth Partners's 13F filing for Q1 2026, filed 1 May 2026.